Skip to main content
LLY
NYSE Life Sciences

Eli Lilly Projects $82B-$85B in Full-Year Revenue

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$877.5
Mkt Cap
$804.239B
52W Low
$623.78
52W High
$1,133.95
52W Position info
41% above low
Off High info
23% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

LLY sits 41% above its 52-week low of $623.78.

Summary

Eli Lilly has provided full-year revenue guidance, projecting between $82 billion and $85 billion. This forward-looking financial metric is crucial for investors and analysts, as it directly impacts valuation models and future growth expectations for the pharmaceutical giant. The guidance follows a period of significant product development news, including positive trial results for its obesity and diabetes drugs, Foundayo and Zepbound/Mounjaro, as well as reports of potential M&A activity. While the headline itself doesn't provide context on whether this guidance beats or misses analyst consensus, the sheer magnitude of the projected revenue for a company of Eli Lilly's size makes it a material update. Traders will be incorporating these figures into their models and watching for further details on the drivers of this revenue, particularly from its blockbuster drugs and pipeline developments.

At the time of this announcement, LLY was trading at $877.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $804.2B. The 52-week trading range was $623.78 to $1,133.95. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,439.99 info
Change: -$12.70 (-0.87%) info
Market Cap: $1.358T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,439.99 info
Change: -$7.86 (-0.54%) info
Market Cap: $1.358T info
LLY
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1,411.12
Real-time Price: $1,439.99 info
Change: +$28.87 (+2%) info
Market Cap: $1.358T info
LLY
Nov 09, 2026, 10:23 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1,394.15
Real-time Price: $1,439.99 info
Change: +$45.84 (+3%) info
Market Cap: $1.358T info
LLY
Nov 06, 2026, 6:45 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,346.00
Real-time Price: $1,439.99 info
Change: +$93.99 (+7%) info
Market Cap: $1.358T info